Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01085617 · clinicaltrials.gov ↗
COMPLETED
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University College, London